Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are being investigated as potential therapies for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding benefits and risks of the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews Jg. 5; S. CD013600
Hauptverfasser:	Piechotta, Vanessa, Iannizzi, Claire, Chai, Khai Li, Valk, Sarah J, Kimber, Catherine, Dorando, Elena, Monsef, Ina, Wood, Erica M, Lamikanra, Abigail A, Roberts, David J, McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J, Skoetz, Nicole
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 20.05.2021
Schlagworte:	Bias Cause of Death COVID-19 - mortality COVID-19 - therapy COVID-19 Serotherapy Humans Immunization, Passive - adverse effects Immunization, Passive - methods Immunization, Passive - mortality Immunization, Passive - statistics & numerical data Non-Randomized Controlled Trials as Topic - statistics & numerical data Pandemics Randomized Controlled Trials as Topic - statistics & numerical data Respiration, Artificial - statistics & numerical data Treatment Outcome Ventilator Weaning - statistics & numerical data
ISSN:	1469-493X, 1469-493X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!